Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 27 citing articles:

A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer
Tanya B. Dorff, Lisa G. Horvath, Karen A. Autio, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 8, pp. 1488-1500
Closed Access | Times Cited: 12
Physiological Considerations for Modeling in vivo Antibody-Target Interactions
Tyler Dunlap, Yanguang Cao
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 25
PBPK Modeling for Enhanced Drug Therapy in the Elderly Population and the Impact of Organ Impairment on Systemic Exposure
Kunj Vyas, David R. Taft
Current Pharmacology Reports (2025) Vol. 11, Iss. 1
Closed Access
Indication‐Specific Dosing and Dose‐Evaluation Strategies in New Indications for Non‐Oncology Monoclonal Antibodies
Sherouk M. Tawfik, Fei Tang
The Journal of Clinical Pharmacology (2025)
Open Access
Advancing Subcutaneous Dosing Regimens for Biotherapeutics: Clinical Strategies for Expedited Market Access
Beate Bittner, Johannes Schmidt
BioDrugs (2023) Vol. 38, Iss. 1, pp. 23-46
Open Access | Times Cited: 9
Improved antibody pharmacokinetics by disruption of contiguous positive surface potential and charge reduction using alternate human framework
Romain Ollier, Aline Fuchs, Florence Gauye, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Turn On, Tune In, Turnover! Target Biology Impacts In Vivo Potency, Efficacy, and Clearance
Johan Gabrielsson, Stephan Hjorth
Pharmacological Reviews (2023) Vol. 75, Iss. 3, pp. 416-462
Open Access | Times Cited: 6
Adalimumab artritis erreumatoidearen tratamendurako: azken urteetako ikasketak
Enara Larreta Carrera, Manoli Igartua Olaechea, Rosa Marı́a Hernández, et al.
EKAIA Euskal Herriko Unibertsitateko Zientzi eta Teknologi Aldizkaria (2024), Iss. 46, pp. 205-225
Open Access | Times Cited: 1
Investigating brain uptake of a non-targeting monoclonal antibody after intravenous and intracerebroventricular administration
Arthur J. Van De Vyver, Antje‐Christine Walz, Mariette Heins, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Artificial Intelligence/Machine Learning and Mechanistic Modeling Approaches as Translational Tools to Advance Personalized Medicine Decisions
George A. Mystridis, Fani Chatzopoulou, George P. Patrinos, et al.
Advances in Molecular Pathology (2022) Vol. 5, Iss. 1, pp. 131-139
Closed Access | Times Cited: 6
A Mechanistic Physiologically‐Based Pharmacokinetic Platform Model to Guide Adult and Pediatric Intravenous and Subcutaneous Dosing for Bispecific T Cell Engagers
Xinwen Zhang, Annie Lumen, Hansen Wong, et al.
Clinical Pharmacology & Therapeutics (2023) Vol. 115, Iss. 3, pp. 457-467
Open Access | Times Cited: 3
Mechanism-based pharmacokinetic and pharmacodynamic modeling for bispecific antibodies: challenges and opportunities
Jin Niu, Weirong Wang, Danièle Ouellet
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 10, pp. 977-990
Closed Access | Times Cited: 3
Single-Dose P2 X4R Single-Chain Fragment Variable Antibody Permanently Reverses Chronic Pain in Male Mice
Karin N. Westlund, Marena A. Montera, Aleyah E. Goins, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13612-13612
Open Access | Times Cited: 7
Monitoring mAb proteoforms in mouse plasma using an automated immunocapture combined with top‐down and middle‐down mass spectrometry
Jonathan Dhenin, Valérie Lafont, Mathieu Dupré, et al.
PROTEOMICS (2023) Vol. 24, Iss. 3-4
Open Access | Times Cited: 2
Phage-derived anti-idiotype and anti-YTE antibodies in development of MK-1654 pharmacokinetic and immune response assays
April Li, Michael D. Swanson, Nicole Sullivan, et al.
Bioanalysis (2023) Vol. 15, Iss. 16, pp. 1049-1067
Closed Access | Times Cited: 2
A Proximity-Dependent Biosensor System for Visualizing Cell-Cell Interactions Induced by Therapeutic Antibodies
Yu Tang, Xiaozhi Liao, Yanguang Cao
Journal of Pharmaceutical Sciences (2023) Vol. 113, Iss. 3, pp. 579-586
Closed Access | Times Cited: 2
Pre-analytical stability of ocrelizumab in serum after delayed centrifugation of whole blood
Jeongsup Shim, Montserrat Carrasco‐Triguero, Saloumeh K Fischer
AAPS Open (2024) Vol. 10, Iss. 1
Open Access
Steered molecular dynamics simulation as a post-process to optimize the iBRAB-designed Fab model
Phuc-Chau Do, Vy Truc Le
Journal of Computer-Aided Molecular Design (2024) Vol. 38, Iss. 1
Closed Access
Local depletion of large molecule drugs due to target binding in tissue interstitial space
Tatiana Zasedateleva, Stephan Schaller, Elizabeth C. M. de Lange, et al.
CPT Pharmacometrics & Systems Pharmacology (2024)
Open Access
Optimization of Transcardiac Perfusion for More Accurately Evaluating Biodistribution of Large Molecules
Zuoxu Xie, Annie Guo, Ekta Kadakia
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12180-12180
Open Access
Personalized therapy using drug delivery devices
Dániel András Drexler, Borbála Gergics, Melánia Puskás, et al.
IFAC-PapersOnLine (2024) Vol. 58, Iss. 24, pp. 550-555
Open Access
Monitoring mAb proteoforms in mouse plasma using an automated immunocapture combined with top-down and middle-down mass spectrometry
Jonathan Dhenin, Valérie Lafont, Mathieu Dupré, et al.
(2023)
Open Access | Times Cited: 1
Leveraging neural crest pluripotency to extend retinal and craniofacial niches for building neurovascular organoids—a theranostic and drug development perspective
Maryada Sharma, Sonal Jangra, Shalini Dhiman, et al.
Elsevier eBooks (2023), pp. 55-118
Closed Access | Times Cited: 1
Pharmacokinetics and Main Metabolites of Anwulignan in Mice
Cong Chen, Yanbo Feng, Han Li, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 1
Impact of charge patches on tumor disposition and biodistribution of therapeutic antibodies
Jakob C. Stüber, Karin Farah Rechberger, Saša M. Miladinović, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top